#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Sexually transmitted disease Mantle cell lymphoma refractory Glomerulonephritis minimal lesion Erythema multiforme Peritoneal mesothelioma malignant Myotonia Tuberous sclerosis complex Renal cell carcinoma Pulmonary tuberculosis Orthostatic hypotension Small for dates baby Hepatocellular carcinoma Pancreatic carcinoma IPEX syndrome Cutaneous T-cell lymphoma More trials…

    Learn about Rare Diseases

    Splenic marginal zone lymphoma Activated PI3 kinase delta syndrome – Trials in Disease Primary mediastinal large B-cell lymphoma – Life with Disease Inclusion body myositis – Trials in Disease Chondrosarcoma Congenital generalised lipodystrophy – Trials in Disease Ewing’s sarcoma metastatic – Diagnostics Carcinoid syndrome – Basic Information Cystic fibrosis – Treatment Medulloblastoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    SEPOFARSEN Dextromethorphan Hydrobromide Setmelanotide Ep262 SAR445399 Folinic Acid Mps-215 Jab-21822 Oxcarbazepine TAGRAXOFUSP Mycophenolate Mofetil IBUZATRELVIR Exenatide Omp12 Noradrenaline Tartrate ICEF15 Tng462 Somapacitan Cinnarizine Dc-806 More therapies…

    Learn about Your Condition

    Uveal melanoma Liposarcoma recurrent Intracranial calcification Essential hypertension Bronchostenosis Herpes zoster Immunodeficiency Endometrial cancer stage IV Dermatomyositis Alveolar rhabdomyosarcoma Cutaneous T-cell lymphoma Autoimmune haemolytic anaemia Cardiac failure chronic Spinal osteoarthritis Schizoaffective disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Oscar Lambret

Centre Oscar Lambret

3 Rue Frederic Combemale, Lille, 59000, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Darolutamide, Triptorelin, and Leuprorelin Acetate for Patients with Newly Diagnosed Prostate Cancer and Pelvic Lymph Node Metastases

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Metastases to lymph nodes
    • Prostate cancer
    Investigated Drugs:
    • Darolutamide
    • Degarelix
    • Leuprorelin Acetate
    France

  • Study Comparing Chemotherapy Alone to Dostarlimab, Paclitaxel, and Carboplatin for Patients with Advanced or Metastatic Endometrial Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Endometrial cancer
    Investigated Drugs:
    • Carboplatin
    • Dostarlimab
    • Paclitaxel
    France Italy Romania Spain

  • Study of INCB099280 and Adagrasib for Adults with Advanced Solid Tumors with KRASG12C Mutation

    Not yet recruiting

    1 1 1
    Investigated Drugs:
    • Adagrasib
    • Incb099280
    France Italy Spain

  • Study on the Effectiveness of Carboplatin and Paclitaxel in Treating Cervical Cancer with Para-aortic Lymph Node Involvement

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Cervix carcinoma
    • Cervix carcinoma stage III
    • Cervix carcinoma stage IV
    Investigated Drugs:
    • Carboplatin
    • Paclitaxel
    France

  • Study comparing XL092 plus nivolumab versus sunitinib for patients with advanced or metastatic non-clear cell kidney cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal cell carcinoma
    Investigated Drugs:
    • N-(4-Fluorophenyl)-N-(4-((7-Methoxy-6-(Methylcarbamoyl)Quinolin-4- Yl)Oxy)Phenyl)Cyclopropane-1,1-Dicarboxamide
    • Nivolumab
    • Sunitinib
    Bulgaria Croatia Czechia Denmark Finland France +8

  • Study of xaluritamig compared to cabazitaxel or androgen receptor therapy for patients with metastatic castration-resistant prostate cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Abiraterone Acetate
    • Cabazitaxel
    • Enzalutamide
    Austria Belgium Denmark France Germany Greece +5

  • Study of tuvusertib combined with niraparib or lartesertib for patients with ovarian cancer that worsened after previous PARP inhibitor treatment

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • 2-Amino-6-Fluoro-N-(5-Fluoro-4-(1-Methyl-1H-Imidazol-5-Yl)Pyridin-3-Yl)Pyrazolo[1,5-A]Pyrimidine-3-Carboxamide
    • 8-(1,3-Dimethylpyrazol-4-Yl)-1-(3-Fluoro-5-Methoxypyridin-4-Yl)-7-Methoxy-3-Methylimidazo[4,5-C]Quinolin-2-One
    • Niraparib Tosilate Monohydrate
    Belgium Denmark France Germany Italy The Netherlands +2

  • A Study of Camizestrant Compared to Standard Hormone Therapy for Patients with ER-Positive HER2-Negative Early Breast Cancer After Initial Treatment

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Abemaciclib
    • Anastrozole
    • Camizestrant
    Austria Belgium Bulgaria Croatia Czechia Estonia +10

  • Study of Tarlatamab alone or with FOLFIRI chemotherapy for patients with advanced digestive system or unknown origin neuroendocrine carcinomas

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Neuroendocrine carcinoma
    Investigated Drugs:
    • Fluorouracil
    • Folinic Acid
    • Irinotecan Hydrochloride Trihydrate
    France Spain

  • Study of bemarituzumab treatment for patients with solid tumors that have high levels of FGFR2b protein

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Breast cancer
    • Cervix carcinoma recurrent
    • Cholangiocarcinoma
    Investigated Drugs:
    • Bemarituzumab
    Austria Belgium Bulgaria Czechia Denmark Finland +9
Previous Page
1 … 13 14 15 16 17 … 26
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!